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Abstract The cerebrospinal fluid (CSF) of patients suffering 
from Creutzfeldt-Jakob disease (CJD) display two unique 
polypeptide chains by two-dimensional poly acrv lamido gel 
electrophoresis (2-D PAGE). In the absence of a well-defined 
ante-mortem diagnostic test for bovine spongiform encephalo-
pathy (BSE), spinal fluid samples of eight normal cows and eight 
cows known to carry BSE by post-mortem histological analysis 
were investigated to verify if equivalent polypeptides were 
present. Proteins with similar migration to human CJD 
polypeptides were not detected. But surprisingly, a cluster of 
polypeptide spots that was faint or not detected in normal bovine 
CSF samples was found to be elevated or massively increased in 
BSE CSF samples (more than 10-fold increase). These elevated 
polypeptide chains were identified as apolipoprotein E. 
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1. Introduction 
Creutzfeldt-Jakob disease (CJD) and bovine spongiform 
encephalopathy (BSE) are fatal degenerative neuronal disor-
ders known as the transmissible spongiform encephalopathies 
(TSE). Despite the decline in the number of new cases of BSE, 
most likely because of preventive action, concern about BSE 
and its possible link to C J D remains [1]. Recently, Collinge et 
al. [2] suggested that the molecular weight and glycosylation 
pattern of the PrPS c of the new C J D variant are similar to 
those seen in BSE-infected cattle, but different from other 
C J D patterns. Their method could be used as a post-mortem 
diagnostic tool. It is clear that diagnostic test development is 
required for ante-mortem screening and/or prognostic evalua-
tion of BSE [3]. The cerebrospinal fluid (CSF) of C J D patients 
displays two additional polypeptides on two-dimensional pol-
yacrylamide gel electrophoresis [4-6]. The function of these 
14-3-3 polypeptides remains unclear in TSE. To see if the 
same proteins are present in BSE, and thus investigate any 
possible link in the diseases and to search for altered expres-
sion of other proteins, we analysed CSF samples of eight 
normal and eight BSE-affected cows. 
2. Materials and methods 
Detailed materials and methods can be found on our web site at the 
following address : http ://expasy.hcuge.ch/ch2d/technical-info.html/. 
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2.1. CSF samples 
Samples (a kind gift of the Ministry of Agriculture, Fisheries and 
Food of the UK) were collected immediately after death by cisterna 
magna puncture from eight BSE-affected adult British cattle and eight 
normal adult British cattle (not fed ruminant-derived protein). CSF 
samples were stored at — 20°C until 2-D PAGE analysis. 
2.2. Analytical two-dimensional gel electrophoresis 
CSF from eight controls and eight BSE animals was analysed by 
high resolution 2-D PAGE. An aliquot of 500 ul of bovine CSF was 
mixed with 1000 ul of ice-cold acetone and centrifuged at lOOOOXg at 
4°C for 10 min. The pellet was mixed with 10 [il of a solution con-
taining SDS (10% w/v) and DTE (2.3% w/v). The sample was heated 
to 95°C for 5 min and then diluted to 60 ul with a solution containing 
urea (8 M), CHAPS (4% w/v), Tris (40 mM), DTE (65 mM) and a 
trace of bromophenol blue. The whole final diluted CSF sample (100 
ug) was loaded on the first dimensional separation. A commercial 
sigmoidal immobilised pH gradient (IPG) from pH 3.5 to 10.0 was 
used for first dimensional separation [7]. After equilibration, the IPG 
gel strips were transferred for the second dimension onto vertical 
gradient slab gels (9-16% T) and run with the Laemmli-SDS discon-
tinuous system [8]. Protein detection was achieved using a sensitive 
ammoniacal silver stain [7], Silver-stained gels were scanned and the 2-
D PAGE images were analysed using the MELANIE II software 
package. Spots were detected and quantified automatically. The opti-
cal density, the area and the volume were computed and directly 
related to protein concentration. The relative optical density and rel-
ative volume were also calculated in order to correct for differences in 
gel staining. 
2.3. Preparative two-dimensional gel electrophoresis 
An aliquot of 5 ml of CSF from BSE-affected cattle was mixed with 
10 ml of ice-cold acetone and centrifuged at lOOOOXg at 4°C for 10 
min. The pellet was mixed with 500 ul of a solution containing urea (8 
M), CHAPS (4% w/v), DTE (65 mM), Resolytes 4-8 (2% v/v) and a 
trace of bromophenol blue. This whole final diluted CSF sample (1 
mg) was used for in-gel sample rehydration before first dimensional 
separation [9]. A home-made narrow immobilised pH gradient (IPG) 
of pH 4-6 was used for first dimensional separation. After equilibra-
tion, the IPG gel strips were transferred onto vertical gradient slab 
gels (9-16% T) for the second dimension [8]. Then, electroblotting 
onto PVDF membranes was done using a home-made semi-dry appa-
ratus with 10% methanol and 10 mM CAPS as buffer (pH fl) at 200 
V for 2 h. After electrotransfer, the PVDF membranes were stained in 
a solution containing amido black (0.5% w/v), isopropanol (25% v/v) 
and acetic acid (10% v/v) for 1 min. Destaining was done by several 
soakings in deionised water. The amido black-stained polypeptides of 
interest were excised with a razor blade and N-terminal sequence 
determination was performed (20 cycles) using an ABI model 473A 
or 477A microsequencer from Applied Biosystems equipped with Pro-
blott cartridges. 
2.4. Immunoblotting 
In order to confirm the apolipoprotein E identification, a polyclonal 
sheep antibody against human ApoE was used for immunoblotting 
(Chemicon International Ltd). The PVDF membrane of a 2-D PAGE 
BSE-affected cattle CSF sample was stained with amido black and 
scanned. The membrane was first blocked with a blocking solution 
(5% (w/v) dry low fat milk, 0.5% (v/v) Tween 20 and 10 mM PBS (pH 
7.4)) for 30 min, probed in the same solution containing 1:500 of the 
primary polyclonal antibody against apolipoprotein E for 2 h and 
washed for 3X10 min in 10 mM PBS (pH 7.4) and 0.5% (v/v) Tween 
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Fig. 1. Silver-stained 2-D PAGE image of BSE-affected CSF. Proteins identified by Edman degradation were: (1) albumin, (2) transferrin, 
(3) a-antitrypsin, (4) immunoglobulin-y heavy chains, (5) apolipoprotein J a chain, (6) apolipoprotein J ß chain, (7) apolipoprotem E, (8) im-
munoglobulin light chains, (9) prostaglandin-D synthase, (10) apolipoprotein Al and (11) transthyretin. The boxed square shows the area en-
larged in Fig. 2. 
20. The secondary goat anti-sheep antibody (1:1000, DAKO) labelled 
with peroxidase was mixed with the blocking solution. The membrane 
was soaked in the latter solution for 1 h and then washed for 4X10 
min in 10 mM PBS (pH 7.4) and 0.5% (v/v) Tween 20. Protein de-
tection was achieved using enhanced chemiluminescence and X-ray 
films as described by the manufacturer (Boehringer Mannheim). The 
films were scanned using a laser densitometer and the 2-D PAGE 
image computer analysis and comparison were carried out using the 
MELANIE II software package. 
3. Results 
A bovine CSF 2-D PAGE protein map was first established 
and polypeptides were identified by amino acid microsequenc-
ing (Fig. 1). Spots equivalent to those found in CJD were not 
detected. However, a cluster of five or six spots was either 
absent or faint in normal bovine CSF and elevated or mas-
sively increased in BSE samples (Fig. 2). They covered a p / of 
5.1-5.3 and a MT of 34-37 kDa. N-terminal microsequencing 
of three of the spots gave the sequence D-M-E-G-E-L-G-P-E-
E-P-L-X-X-Q-Q-P-R-X-K which identified the polypeptides 
as bovine apolipoprotein E (bApoE). Polyclonal antibodies 
against human ApoE confirmed this identification and re-
vealed that all the polypeptides in the cluster were isoforms 
of bApoE. By densitometric measurement, a 10-fold difference 
was seen between the levels of bApoE in BSE samples. By 
densitometric measurement, all BSE-affected samples showed 
Fig. 2. Control CSF samples (a, b, c); BSE-affected CSF samples (d, e, f). The three arrows show the microsequenced spots, and the two ar-
rowheads show additional spots identified with immunoblotting. 
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Fig. 3. Apolipoprotein E level quantitation. Total protein in each 
CSF sample was assayed according to Bradford [17], and percent 
volume of spot density was then used to calculate approximate apo-
lipoprotein E concentration. 
higher levels of ApoE than normal samples (Fig. 3). Overall, 
this represented a significant difference in concentration 
(P< 0.001). Interestingly, there was little variation in the 
quantity of ApoE detected in normal samples; however, a 
15-fold difference in ApoE quantity was seen within the set 
of samples from BSE-affected animals. We could not establish 
in this study if this difference in ApoE quantity in BSE-af-
fected animals correlated with the severity of the disease in 
each case. 
4. Discussion 
The role of the ApoE in the nervous system has been ex-
tensively studied, but its function remains incompletely under-
stood. ApoE is known to play a role in nerve growth and 
nerve regeneration, and some of its phenotypes appear to 
affect susceptibility to Alzheimer's disease in humans [10-
12]. Interestingly, the level of ApoE is known to be elevated 
in several situations, including following peripheral nerve in-
jury [13] in activated astrocytes in Alzheimer's disease [14], 
and in the brains of mice infected with scrapie [15]. Our dis-
covery of elevated levels of ApoE in the CSF of BSE-affected 
cows is thus significant and correlates with the previous results 
described by Jones et al. [16], as it further implicates the in-
volvement of this protein in abnormal neuronal processes, 
including prion diseases. Perhaps more importantly, it 
presents a possible means of screening cattle for the nerve 
damage that accompanies BSE. The present paper described 
direct sequence determination of the N-terminus of three of 
the altered 2-D spots corresponding to bovine apolipoprotein 
E. We are currently undertaking a time course study in a 
larger group of cattle to determine when ApoE elevation takes 
place in the disease course, and if a threshold level of ApoE 
can be established for early diagnosis of BSE. 
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